| Stage | ARXS | % of rev | NP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $564M | 100.00% | $60M | 100.00% | ARXS ×9.47 |
| Gross profit | $306M | 54.27% | $60M | 100.00% | NP +45.7pp |
| Operating income | $133M | 23.66% | $28M | 46.95% | NP +23.3pp |
| Pre-tax income | $120M | 21.23% | $25M | 41.49% | NP +20.3pp |
| Net income | $84M | 14.84% | $17M | 28.97% | NP +14.1pp |
| Stage | ARXS | NP | Gap · A − B |
|---|---|---|---|
| Revenue | $564M100.00% | $60M100.00% | ARXS ×9.47 |
| Gross profit | 54.27%$306M | 100.00%$60M | NP +45.7pp |
| Operating income | 23.66%$133M | 46.95%$28M | NP +23.3pp |
| Pre-tax income | 21.23%$120M | 41.49%$25M | NP +20.3pp |
| Net income |
| 14.84%$84M |
| 28.97%$17M |
| NP +14.1pp |
None
No disclosed counterparties: ARXS.